<DOC>
	<DOCNO>NCT00641225</DOCNO>
	<brief_summary>The purpose study determine safety tolerability single dose SBI-087 subject rheumatoid arthritis .</brief_summary>
	<brief_title>Study Evaluating Single Doses Of SBI-087 Subjects With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>Man nonlactating nonpregnant woman , age 18 70 year , inclusive , screen visit . Must meet criterion rheumatoid arthritis functional class I III . Diagnosis rheumatoid arthritis 6 month study day 1 rheumatoid arthritis onset 16 year age Any significant health problem rheumatoid arthritis . Treatment great 10 mg prednisone per day . Treatment cyclophosphamide .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Ascending Single Dose</keyword>
	<keyword>Safety</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Open-label</keyword>
</DOC>